My dad,65 year old and has advanced NSCLC with bone metastasis ,diagnosed in Feb 2012. The EGRF mutation test is positive and he has been taking Iressa since March 2012.He has been admitted last week with complaint of breathlessness. His cxr showed interstitial lung changes. The Iressa was discontinued as the possibility of its complication of interstitial lung disease and furthermore there are signs of progression. The oncologist has suggested alimta as single therapy for my dad.My dad is still breathless on exertion. We are in dilemma now, whether to agree or to with-hold any chemotherapy at the moment.Advice is much appreciated.thanks.
Wed, 09/12/2012 - 00:53#1
Decision on treatment for NSCLC - 1247932